Wayne L Whittingham

Title: Wayne L. Whittingham: Innovator in Cardiovascular Pharmaceuticals

Introduction

Wayne L. Whittingham is a notable inventor based in Wilmington, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cardiovascular medications. His innovative approach has led to the creation of a unique fixed-dose combination that addresses both hypertension and cholesterol levels.

Latest Patents

Wayne L. Whittingham holds a patent for an "Anti-hypertensive and cholesterol-lowering fixed-dose combination and method of manufacture." This patent discloses a method for manufacturing a cardiovascular fixed-dose combination pharmaceutical dosage form that includes an anti-hypertensive active agent and a cholesterol-lowering active agent. The formulation may also include an enteric-coated aspirin or platelet inhibitor. The innovative aspect of this combination is that it is prepared with at least two granulation solutions that are free of citric acid, enhancing the aqueous solubility of the cholesterol-lowering agent. The resulting dosage form maintains the same strength and release profiles as the active agents prepared as a single formulation. Wayne has 1 patent to his name.

Career Highlights

Throughout his career, Wayne has focused on developing effective pharmaceutical solutions that improve patient outcomes. His work has been instrumental in advancing the field of cardiovascular health, showcasing his dedication to innovation and patient care.

Collaborations

Wayne has collaborated with notable colleagues, including Roy A. Stimits and Daniel Tyree Gregory, Jr. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

Wayne L. Whittingham's contributions to the pharmaceutical industry, particularly in cardiovascular health, highlight his role as an innovator. His patented work continues to influence the development of effective treatments for hypertension and cholesterol management.